Federal health officials last fall touted a new treatment for autism: leucovorin, a derivative of Vitamin B9 commonly used during cancer treatment. But the drugmaker, GSK, this week asked the Food and Drug Administration to pull its application.[#item_full_content]
Report: Campaign Security Costs Top $100 Million
Aprile 10, 2026
Increased threats of political violence have forced federal campaigns and committees to spend more than $100 million on security, according to a report released this
